The Impact of Radiotherapy on Oligometastatic Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Metastasis trials

Trial locations(21 sites)

Spain

Complejo Hospitalario Universitario Albacete, Albacete, Albacete

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona

Institut Català d'Oncologia, Barcelona, Barcelona

Hospital Universitario Virgen de las Nieves, Granada, Granada

Key details

Sponsor

Institut Investigacio Sanitaria Pere Virgili

Collaborators

Hospital Ruber Internacional, Hospital Universitario Rey Juan Carlos

Enrollment target

~2,000 participants

Started

December 2022

Primary completion

December 2037

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

The Impact of Radiotherapy on Oligometastatic Cancer — Stella